Evidence map›Paper›PMID 42020367›Full record

ArticleBlood cancer journal2026

Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response.

Mikhail Roshal, Isabella Y Kong, Wikum Dinalankara, Jonathan B Reichel, Matthew Teater, Bhavneet Binder, Sakellarios Zairis, Joshua D Brody, Sunita I Park, Alexandra E Kovach and 11 more

Abstract read
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Mikhail Roshal *Memorial Sloan Kettering Cancer Center, New York, NY, USA. roshalm@mskcc.org.
Isabella Y Kong *Weill Cornell Medicine, New York, NY, USA.
Wikum DinalankaraWeill Cornell Medicine, New York, NY, USA.
Jonathan B ReichelMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Matthew TeaterWeill Cornell Medicine, New York, NY, USA.
Bhavneet BinderWeill Cornell Medicine, New York, NY, USA.
Sakellarios ZairisProgram for Mathematical Genomics, Departments of Systems Biology and Biomedical Informatics, Columbia University, New York, NY, USA.
Joshua D BrodyIcahn School of Medicine at Mount Sinai, New York, NY, USA.
Sunita I ParkChildren's Healthcare of Atlanta, Atlanta, GA, USA.
Alexandra E KovachChildren's Hospital of Los Angeles, Los Angeles, CA, USA.
Nitya GulatiWeill Cornell Medicine, New York, NY, USA.
Matthew J OberleyChildren's Hospital of Los Angeles, Los Angeles, CA, USA.
Megan S LimMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Matthew J BarthRoswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Olivier ElementoWeill Cornell Medicine, New York, NY, USA.ORCID 0000-0002-8061-9617
Ari MelnickWeill Cornell Medicine, New York, NY, USA.ORCID 0000-0002-8074-2287
Raul RabadanProgram for Mathematical Genomics, Departments of Systems Biology and Biomedical Informatics, Columbia University, New York, NY, USA.
Amy ChadburnWeill Cornell Medicine, New York, NY, USA.
Luigi MarchionniWeill Cornell Medicine, New York, NY, USA.
Lisa Giulino-RothWeill Cornell Medicine, New York, NY, USA. lisa.roth@nyulangone.org.
Ethel CesarmanWeill Cornell Medicine, New York, NY, USA. ecesarm@med.cornell.edu.ORCID 0000-0003-3303-6299

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Tri-Institutional Training Program in Computational Biology & MedicineT32GM083937 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHRISTINI, DAVID J. · 2009 to 2018
$3.1M
Survival Signals in AIDS LymphomasR01CA068939 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CESARMAN, ETHEL · 2001 to 2010
$2.6M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA068939NIGMS NIH HHS T32 GM083937U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01-CA068939U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) 5T32GM083937
6 · The paper itself

Abstract

Classic Hodgkin lymphoma (cHL) shares mutations with primary mediastinal B cell lymphoma (PMBL) but differs in histology, clinical behavior, and phenotype. To define transcriptional programs underlying these differences, we performed flow cytometric cell sorting and low-input RNA sequencing of Hodgkin and Reed-Sternberg (HRS) cells from eighteen primary tumors, paired intra-tumoral B cells, and four cHL cell lines, and compared them with RNA-sequencing data from 40 PMBL cases. Transcriptomic profiling revealed that HRS cells undergo abortive plasma cell differentiation with robust activation of the unfolded protein response (UPR), a feature shared with multiple myeloma but absent in diffuse large B cell lymphoma and PMBL. HRS cells also demonstrated profound immune evasion, including suppression of B cell identity genes and loss of natural killer cell recognition through downregulation of SLAM family ligands such as CD48. Comparative analysis with PMBL highlighted shared oncogenic programs and key distinctions: HRS cells exhibited greater loss of B cell identity, absence of GCB- and plasma cell markers, and unique upregulation of cytoskeletal and mitotic pathways consistent with their multinucleated morphology. These findings establish HRS cells as aberrantly differentiated GCB cells with partial plasmacytic features, UPR activation and distinct immune evasion strategies.

Indexed as

Hodgkin DiseaseKiller Cells, NaturalReed-Sternberg CellsTranscriptomeTumor EscapeUnfolded Protein ResponseCell Line, TumorGene Expression ProfilingHumans

Identifiers

PMID42020367
PMCPMC13392450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.